Clinical Trial Update: Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of oxaliplatin and docetaxel followed by cetuximab for head and neck cancer has been terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Head and Neck Cancer, Carcinoma, Squamous | Phase 2 | Status: TERMINATED | Results posted: 2017-06-14